Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.43 |
| ▸ | CA1 | P00915 | 3/20 | 0.43 |
| ▸ | CA2 | P00918 | 3/20 | 0.43 |
| ▸ | CA12 | O43570 | 2/20 | 0.43 |
| ▸ | CA7 | P43166 | 2/20 | 0.43 |
| ▸ | CA9 | Q16790 | 2/20 | 0.43 |
| ▸ | CA14 | Q9ULX7 | 2/20 | 0.43 |
| ▸ | CA4 | P22748 | 1/20 | 0.43 |
| ▸ | NR3C2 | P08235 | 1/20 | 0.43 |
| ▸ | GAA | P10253 | 4/20 | 0.42 |
| ▸ | MEN1 | O00255 | 3/20 | 0.41 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.41 |
| ▸ | TP53 | P04637 | 1/20 | 0.41 |
| ▸ | TSHR | P16473 | 1/20 | 0.41 |
| ▸ | HTT | P42858 | 3/20 | 0.40 |
| ▸ | CASR | P41180 | 1/20 | 0.40 |
| ▸ | ENPP2 | Q13822 | 1/20 | 0.38 |
| ▸ | ORAI1 | Q96D31 | 1/20 | 0.37 |
| ▸ | ORAI2 | Q96SN7 | 1/20 | 0.37 |
| ▸ | ORAI3 | Q9BRQ5 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18550496 | 0.86 | NFE2L2 (0.41) | ALDH1A1CA1CA2CA12CA7 | |
| SCHEMBL6568167 | 0.81 | CYP19A1 (0.51) | ALDH1A1CA1CA2CA12CA7 | |
| SCHEMBL4599958 | 0.81 | CYP19A1 (0.48) | ALDH1A1CA1CA2CA12CA7 | |
| SCHEMBL28117527 | 0.80 | CES1 (0.47) | ALDH1A1CA4KMT2ATSHRSMN1; SMN2 | |
| SCHEMBL18545738 | 0.79 | CASR (0.51) | ALDH1A1CA1CA2CA12CA7 | |
| SCHEMBL221217 | 0.77 | CA1 (0.46) | ALDH1A1CA1CA2CA12CA7 | |
| SCHEMBL221587 | 0.77 | CA1 (0.46) | ALDH1A1CA1CA2CA12CA7 | |
| SCHEMBL6257499 | 0.77 | CA1 (0.46) | ALDH1A1CA1CA2CA12CA7 | |
| SCHEMBL7713128 | 0.77 | CA1 (0.46) | ALDH1A1CA1CA2CA12CA7 | |
| SCHEMBL28318661 | 0.77 | CA1 (0.52) | ALDH1A1CA1CA2CA12CA7 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 55 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-104178134-B | Novel luminescent material | 辽宁大学 | 2017-01-25 | — | — | CN | claimed |
| US-11796919-B2 | Resist pattern formation method | OSAKA UNIVERSITY (JP) | 2023-10-24 | — | — | US | disclosed |
| CN-111562720-B | Photo-sensitized chemically amplified resist material, pattern forming method, semiconductor device, mask for lithography, and template for nanoimprint | 东京毅力科创株式会社 | 2023-09-29 | — | — | CN | disclosed |
| CN-113816837-B | Synthesis method of 4,4' -dimethoxy triphenylchloromethane | 连云港冠昕医药科技有限公司 | 2023-09-19 | — | — | CN | disclosed |
| US-20210216016-A1 | RESIST PATTERN FORMATION METHOD | OSAKA UNIVERSITY (JP) | 2021-07-15 | — | — | US | disclosed |
| EP-3809206-A1 | RESIST PATTERN FORMATION METHOD | Osaka University (JP) | 2021-04-21 | — | — | EP | disclosed |
| CN-112272798-A | Resist pattern forming method | 国立大学法人大阪大学 | 2021-01-26 | — | — | CN | disclosed |
| EP-3109703-B1 | PHOTOSENSITIZATION CHEMICAL-AMPLIFICATION TYPE RESIST MATERIAL, AND METHOD FOR FORMING PATTERN USING SAME | TOKYO ELECTRON LTD (JP) | 2020-12-30 | — | — | EP | disclosed |
| CN-111562720-A | Photosensitizing chemically amplified resist material, method for forming pattern, semiconductor device, mask for lithography, and template for nanoimprint | 东京毅力科创株式会社 | 2020-08-21 | — | — | CN | disclosed |
| CN-106030417-B | Photosensitizing chemically amplified resist material, method for forming pattern using same, semiconductor device, mask for lithography, and method for manufacturing template for nanoimprinting | 东京毅力科创株式会社 | 2020-02-28 | — | — | CN | disclosed |
| US-20030203957-A1 | Selected fused pyrrolocarbazoles | CEPHALON, INC. | 2003-10-30 | — | — | US | disclosed |
| US-6630500-B2 | Treating angiogenic disorders | CEPHALON, INC. | 2003-10-07 | — | — | US | disclosed |
| EP-1311263-A2 | FUSED PYRROLOCARBAZOLES AGAINST INFLAMMATION | CEPHALON, INC. (US) | 2003-05-21 | — | — | EP | disclosed |
| US-20020061920-A1 | Selected fused pyrrolocarbazoles | CEPHALON, INC. | 2002-05-23 | — | — | US | disclosed |
| WO-2002017914-A2 | FUSED PYRROLOCARBAZOLES AGAINST INFLAMMATION | CEPHALON, INC. (US) | 2002-03-07 | — | — | WO | disclosed |
| EP-1165508-A1 | ANTICANCER CALCIUM CHANNEL BLOCKERS | Gray, Lloyd S. (US) | 2002-01-02 | — | — | EP | disclosed |
| WO-2000059882-A9 | ANTICANCER CALCIUM CHANNEL BLOCKERS | GRAY LLOYD S (US) | 2001-11-29 | — | — | WO | disclosed |
| WO-2000059882-A1 | ANTICANCER CALCIUM CHANNEL BLOCKERS | GRAY LLOYD S (US) | 2000-10-12 | — | — | WO | disclosed |
| EP-0934260-A1 | N ALPHA-2-(4-NITROPHENYLSULFONYL)ETHOXYCARBONYL-AMINO ACIDS | Hyundai Pharm. Ind. Co., Ltd. (KR) | 1999-08-11 | — | — | EP | disclosed |
| WO-1998017638-A1 | Nα-2-(4-NITROPHENYLSULFONYL)ETHOXYCARBONYL-AMINO ACIDS | HYUNDAI PHARM. IND. CO., LTD. (KR) | 1998-04-30 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20020061920-A1 | Selected fused pyrrolocarbazoles | CYP11B2, PC, CYP4F3 | ALDH1A1 498/4885CA1 3062/4885CA2 2093/4885 |
| US-20030203957-A1 | Selected fused pyrrolocarbazoles | CYP11B2, PC, CYP4F3 | ALDH1A1 498/4885CA1 3062/4885CA2 2093/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.